US Broker Ratings

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 30% Upside Potential in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a Spanish multinational company, is a significant player in the healthcare sector, specializing as a drug manufacturer with a primary focus on plasma-derived medicines. With a..

BrightSpring Health Services, I (BTSG)

⚠️ No article content returned.

..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Unveiling Growth Potential with a 9.10% Upside

Bausch + Lomb Corporation (NYSE: BLCO), a renowned name in the healthcare sector, is capturing investor interest with its promising outlook and significant market presence. Operating within the medical instruments..

Baxter International Inc. (BAX) Stock Analysis: A 30% Upside Potential Amidst Market Challenges

Investors eyeing the healthcare sector may want to take a closer look at Baxter International Inc. (NYSE: BAX), a company renowned for its diverse portfolio of healthcare products and global..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Is an 8.9% Upside Worth Your Investment?

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector specializing in medical devices, stands as a pivotal entity in the life sciences and clinical diagnostics fields. With..

Centene Corporation (CNC) Stock Analysis: Navigating Growth Amidst a Shifting Healthcare Landscape

Centene Corporation (NYSE: CNC), a major player in the healthcare plans sector, offers a compelling opportunity for investors seeking exposure to the healthcare industry. With a market capitalization of $17.38..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 22% Potential Upside Amidst Robust Revenue Growth

Madrigal Pharmaceuticals, Inc. (MDGL), headquartered in West Conshohocken, Pennsylvania, stands out in the biotechnology sector with its focus on addressing metabolic dysfunction-associated steatohepatitis (MASH) through novel therapeutics. With a market..

Incyte Corporation (INCY) Stock Analysis: Evaluating the Growth Potential Amidst a 20% Revenue Surge

Incyte Corporation (NASDAQ: INCY) stands out in the biotechnology industry with its impressive 20% revenue growth, positioning itself as a significant player in the healthcare sector. With a market capitalization..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring a 7.88% Potential Upside in the Organ Transplant Market

TransMedics Group, Inc. (NASDAQ: TMDX) stands out in the healthcare sector with its innovative approach to organ transplant technology. The Massachusetts-based company, with a market capitalization of $4.5 billion, is..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Biotech Powerhouse with 23% Potential Upside

For investors eyeing opportunities in the healthcare sector, BeOne Medicines Ltd. (ONC) presents a compelling case with its impressive market footprint and robust development pipeline. Specializing in oncology treatments, this..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Healthcare Landscape with a Remarkable 52-Week Range

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands as a unique player in the healthcare sector, specifically within the realm of drug manufacturing specializing in traditional Chinese medicine (TCM). Headquartered in..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a Potential 31% Upside

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical devices sector, presents a compelling case for investors seeking opportunities in the healthcare industry. With a current market capitalization..

Corcept Therapeutics (CORT) Investor Outlook: A Promising 84% Upside Amidst Biotech Innovations

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, is capturing attention with a significant potential upside of 84.09%, as indicated by analyst target prices. This Redwood..

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech with 24.98% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is capturing investor attention with its focus on developing innovative therapies for cancer patients. Headquartered in Cambridge, Massachusetts, Nuvalent operates within the..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Potential Upside with a Strong Dividend Yield

Fresenius Medical Care AG (NYSE: FMS), a prominent player in the healthcare sector, specializes in providing dialysis and related services to individuals with renal diseases. Headquartered in Bad Homburg, Germany,..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unveiling a 16% Potential Upside in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its compelling growth metrics and strategic partnerships. With a market capitalization of $7.63 billion, Halozyme is a..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Uncovering a Potential 26.51% Upside in Biotechnology

TG Therapeutics, Inc. (NASDAQ: TGTX) has emerged as a notable player in the biotechnology sector, with its strategic focus on innovative treatments for B-cell mediated diseases. With a market capitalization..

Teleflex Incorporated (TFX) Stock Analysis: Navigating the Healthcare Sector with a 6.28% Potential Upside

Teleflex Incorporated (NYSE: TFX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $5.5 billion, this Pennsylvania-based..

Merit Medical Systems (MMSI): Investment Potential with 19.63% Upside and Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector specializing in medical instruments and supplies, is currently capturing the interest of investors with its robust growth..

Bruker Corporation (BRKR) Stock Analysis: Eyeing a 19.3% Upside Potential with Strong Buy Ratings

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly in the medical devices industry, is drawing considerable attention from investors. As of now, Bruker’s market capitalization stands..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds